Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation.
暂无分享,去创建一个
H R Schumacher | G. Chrousos | H. Schumacher | G P Chrousos | R L Wilder | Cheryl H Yarboro | R. Wilder | K. Kanik | K S Kanik | M L Crane | C H Yarboro | M. Crane
[1] S. Bale,et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. , 1999, Arthritis and rheumatism.
[2] J. Bijlsma,et al. Estrogens and Rheumatoid Arthritis , 1992, American journal of reproductive immunology.
[3] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[4] H. Zeidler,et al. Undifferentiated arthritis and reactive arthritis. , 1998, Current opinion in rheumatology.
[5] R. Pope,et al. Effect of pregnancy on immune complexes and rheumatoid factors in patients with rheumatoid arthritis. , 1983, The American journal of medicine.
[6] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[7] R. Wilder. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. , 1996, The Journal of rheumatology. Supplement.
[8] G. Chrousos,et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Reunanen,et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis , 1998, Annals of the rheumatic diseases.
[10] G. Kingsley,et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.
[11] E. Keller,et al. Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. , 1996, The Journal of biological chemistry.
[12] A. Masi,et al. Estrogens, the immune response and autoimmunity. , 1995, Clinical and experimental rheumatology.
[13] W. Regelson,et al. Dehydroepiandrosterone (DHEA)--the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? , 1994, Annals of the New York Academy of Sciences.
[14] W. Regelson,et al. Dehydroepiandrosterone (DHEA)–the Multifunctional Steroid , 1994 .
[15] D. Farber,et al. Dissociation of adrenal androgen and cortisol levels in acute stress. , 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[16] M. Cutolo,et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. , 1999, The Journal of rheumatology.
[17] Xu,et al. Indomethacin Attenuates Oxytocin and Hypothalamic‐Pituitary‐Adrenal Axis Responses to Systemic Interleukin‐1β , 1998, Journal of neuroendocrinology.
[18] G. Panayi. Hormonal control of rheumatoid inflammation. , 1995, British medical bulletin.
[19] G. Chrousos,et al. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. , 1999, The Journal of clinical endocrinology and metabolism.
[20] W. Scherbaum,et al. Regulation of adrenocortical function by cytokines--relevance for immune-endocrine interaction. , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[21] A. Masi,et al. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. , 1999, Seminars in arthritis and rheumatism.
[22] R L Wilder,et al. Neuroendocrine-immune system interactions and autoimmunity. , 1995, Annual review of immunology.
[23] W. Graninger,et al. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. , 1996, British journal of rheumatology.
[24] G. Chrousos,et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. , 1997, The Journal of clinical endocrinology and metabolism.
[25] A. Masi,et al. Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? , 1995, Clinical and experimental rheumatology.
[26] B. Skogseid,et al. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. , 1996, The Journal of rheumatology.
[27] N. Olsen,et al. Castration alters peripheral immune function in normal male mice. , 1995, Immunology.
[28] R. Loria,et al. Dehydroepiandrosterone (DHEA)‐the “Mother Steroid” , 1994 .
[29] A. Silman,et al. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. , 1999, Arthritis and rheumatism.
[30] M. Cutolo,et al. Immunomodulatory Mechanisms Mediated by Sex Hormones in Rheumatoid Arthritis a , 1996, Annals of the New York Academy of Sciences.
[31] E. Morand,et al. Glucocorticoids in rheumatoid arthritis--mediators and mechanisms. , 1993, British Journal of Rheumatology.
[32] D. Papanicolaou,et al. The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.
[33] R. Daynes,et al. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. , 1993, Journal of immunology.
[34] I. Elenkov,et al. Hormonal Regulation of Tumor Necrosis Factor‐α, Interleukin‐12 and Interleukin‐10 Production by Activated Macrophages: A Disease‐modifying Mechanism in Rheumatoid Arthritis and Systemic Lupus Erythematosus? , 1999, Annals of the New York Academy of Sciences.
[35] G. Chrousos,et al. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. , 1993, The Journal of clinical endocrinology and metabolism.
[36] M. V. van Leeuwen,et al. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. , 1995, Annals of the rheumatic diseases.
[37] J. Takahara,et al. Effect of continuous intravenous injection of interleukin-6 and pretreatment with cyclooxygenase inhibitor on brain c-fos expression in the rat. , 1997, Neuroendocrinology.
[38] H. Broxmeyer,et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. , 1995, The Journal of clinical investigation.
[39] Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. , 1998, The Journal of clinical endocrinology and metabolism.
[40] L. Lisá. [Effects of glucocorticoids]. , 1977, Ceskoslovenska pediatrie.
[41] M. Cutolo. The role of the hypothalamus-pituitary-adrenocortical and -gonadal axis in rheumatoid arthritis. , 1998, Clinical and experimental rheumatology.
[42] A. Masi,et al. Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. , 1995, Seminars in arthritis and rheumatism.
[43] L. Bonomo,et al. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. , 1996, Journal of Rheumatology.
[44] H. Zeidler,et al. Undifferentiated arthritis in an early synovitis out-patient clinic. , 1995, Clinical and experimental rheumatology.